Educational information only — not medical advice. Most peptides here are not FDA-approved.
MyPeps
← The Peps Report

Episode 6 · September 29, 2026 · 3:37

Semax and Selank explained: Russia's nasal peptides

Semax and Selank are registered medicines in Russia and unapproved almost everywhere else. What the research shows, July's FDA panel vote, and what's known about Adamax and Adalank.

Show notes

Nicholas covers the two best-known Russian nasal peptides: how they're built, the animal and small human studies behind them, their regulatory status, and the untested analogs Adamax and Adalank.

Read the full post: Semax and Selank explained: Russia's nasal peptides

In this episode

  • 00:00 Cold open and intro
  • 00:38 A shared design trick
  • 01:00 What Semax research shows
  • 01:29 What Selank research shows
  • 01:48 Regulatory status and the July vote
  • 02:17 Adamax and Adalank
  • 02:34 How to think about foreign approvals
  • 03:00 What this adds up to
  • 03:12 Wrap-up and Amino Club code

Peptides covered

Tools and deals

Sources


Educational information only, not medical advice. Talk to a licensed clinician before starting, stopping or changing any medication. Research-grade peptides are not FDA-approved drugs.

Read the article

Semax and Selank explained: Russia's nasal peptides

Semax and Selank are registered medicines in Russia and unapproved almost everywhere else. Here is what the research shows, and what is known about Adamax and Adalank.

Peptides in this episode

This is educational information, not medical advice.